Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field

Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD...

Full description

Saved in:
Bibliographic Details
Published inJACC. Advances (Online) Vol. 2; no. 2
Main Authors Tandon, Animesh, Nguyen, Hoang H, Avula, Sravani, Seshadri, Dhruv R, Patel, Akash, Fares, Munes, Baloglu, Orkun, Amdani, Shahnawaz, Jafari, Roozbeh, Inan, Omer T, Drummond, Colin K
Format Journal Article
LanguageEnglish
Published United States 01.03.2023
Subjects
congenital heart disease
wearables
wearable biosensors
artificial intelligence
Online AccessGet full text

Cover

More Information
Summary:Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2772-963X
2772-963X
DOI:10.1016/j.jacadv.2023.100267